Not investment advice. Educational platform. See Disclaimer.
NASDAQ: IDYA
IDEAYA Biosciences, Inc.
Healthcare | Biotechnology
No licensed closing price on file for IDYA. This page shows the company’s SEC filings and filed figures, without a price or any ratio that depends on one.
EPS (FY2025)$-1.28
IDEAYA Biosciences, Inc. (NASDAQ: IDYA) is a biotechnology company. Figures from SEC EDGAR; updated 2026-10-20 05:59 UTC.
Pre-revenue, development-stage company: standard profitability ratios (P/E, EV/EBITDA, ROE) do not apply yet because there are no earnings. Watch cash, cash runway, net loss, R&D spend and share dilution instead.
2025-06-27Exec ChangeDeparture of directors or certain officers; election of directors; appointment of certain officers; compensatory arrangements of certain officersEstimatedSEC 8-K →
2025-02-10Exec ChangeDeparture of directors or certain officers; election of directors; appointment of certain officers; compensatory arrangements of certain officersEstimatedSEC 8-K →
2023-09-26Exec ChangeDeparture of directors or certain officers; election of directors; appointment of certain officers; compensatory arrangements of certain officersEstimatedSEC 8-K →
IDEAYA Biosciences, Inc. is a biotechnology company, listed on NASDAQ as IDYA.
When did IDYA last file with the SEC?
IDEAYA Biosciences, Inc.'s most recent SEC filing on record is a 8-K filed 2026-06-23. All filings link to their SEC EDGAR originals above.
Where does this data come from?
SEC EDGAR filings, with the company profile (sector, industry, exchange) from public data providers, fetched 2026-10-20 05:59 UTC. This page is also available as JSON at /api/data?ticker=IDYA and is emitted with FAQPage structured data for machine reading.
For you
Charts, 10-year financials, peer comparison, screening and portfolio tracking for IDYA and 5,000+ tickers.
Oxford Ledge
Search